摘要
视神经脊髓炎（Neuromyelitis optica,NMO）,又称Devic病,是一种主要累及视神经和脊髓的中枢神经系统炎性脱髓鞘疾病[1]。总体发病率约为1∶100,000,好发于中年、非白人女性。
出处
《中国实验诊断学》
2014年第11期1907-1909,共3页
Chinese Journal of Laboratory Diagnosis
参考文献2
-
1Sellner J,Boggild M,Clanet M,李海峰,徐雁.欧洲神经病学联盟关于视神经脊髓炎诊治的指南[J].中国神经免疫学和神经病学杂志,2010,17(5):383-385. 被引量：105
-
2关新刚,苏维恒,郝峰,张迪,孙新.视神经脊髓炎患者血清中的AQP4抗体检测[J].中国实验诊断学,2013,17(12):2170-2172. 被引量：4
二级参考文献12
-
1Pittock SJ. Neuromyelitis optica:A new perspective[J].{H}Seminars In Neurology,2008.95.
-
2Wingerchuk DM,Lennon VA,Lucchinetti CF. The spectrum ofneuromyelitis optica[J].{H}Lancet Neurology,2007.805.
-
3Lennon VA,Wingerchuk DM,Kryzer TJ. A serum autoantibody marker of neuromyelitis optica:Distinction from multiplesclerosis[J].{H}LANCET,2004.2106.
-
4Misu T,Fujihara K,Kakita A. Loss of aquaporin 4 in lesions of neuromyelitis optica:Distinction frommultiple sclerosis[J].{H}BRAIN,2007.1224.
-
5Matsuoka T,Matsushita T,Kawano Y. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions inmultiple sclerosis in Japanese[J].{H}BRAIN,2007.1206.
-
6Roemer SF,Parisi JE,Lennon VA. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis[J].{H}BRAIN,2007.1194.
-
7Takahashi T,Fujihara K,Nakashima I. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO:A study on antibody titre[J].{H}BRAIN,2007.1235.
-
8Agre P,Sasaki S,Chrispeels MJ. Aquaporins,a family of membrane water channels[J].{H}American Journal of Physiology,1993.F461.
-
9Carbrey JM,Agre P. Discovery of the aquaporins and development of the field[J].Handb Exp Pharmacol,2009.3.
-
10Verkman AS. Mammalian aquaporins:diverse physiological roles and potential clinical significance[J].{H}Expert reviews in molecular medicine,2008.1.
共引文献107
-
1李海峰.多发性硬化早期的复发造成患者严重残疾的危险有多大?[J].中国神经免疫学和神经病学杂志,2011,18(1):72-73.
-
2戚晓昆.全面掌握中枢神经系统炎性脱髓鞘疾病影像学进展[J].中华神经科杂志,2011,44(7):445-447. 被引量：10
-
3赵彩蕾,谢晟,肖江喜,王爽.儿童多发性硬化的临床特点及MRI特征[J].中华放射学杂志,2011,45(10):942-946. 被引量：4
-
4李继,王倩,张状.以呃逆为首发症状的视神经脊髓炎一例并文献复习[J].中华神经医学杂志,2011,10(12):1284-1285. 被引量：3
-
5于晓莉,张玉琴,朱近,王春祥,许海泉,刘丽珍.视神经脊髓炎的临床特点及预后分析[J].实用儿科临床杂志,2012,27(6):446-448. 被引量：9
-
6郭海霞,张美妮.水通道蛋白4与视神经脊髓炎疾病谱的新进展[J].中国医疗前沿,2012,7(5):18-19.
-
7钟晓南,胡学强.视神经脊髓炎诊断进展[J].中国现代神经疾病杂志,2012,12(2):131-134. 被引量：9
-
8樊永平,胡蕊,鲍显慧,吴畏.63例视神经脊髓炎患者临床特点和中医证型分布[J].中国中西医结合杂志,2013,33(3):322-325. 被引量：25
-
9王颖云,魏世辉,范珂,闫洪欣,张译心,戴艳丽.复发性视神经炎54例临床特点及自身免疫抗体的分布[J].中国实用眼科杂志,2013,31(3):346-349. 被引量：3
-
10袁静静,李泽宇,殷旭华.视神经脊髓炎的研究进展[J].中国神经免疫学和神经病学杂志,2013,20(2):135-137. 被引量：9
同被引文献31
-
1WINGERCHUK DM,BANWELL B,BENNETT JL,et al.In- ternational consensus diagnostic criteria or neuromyelitis ptica pectrum disorders[J].Neurology,2015,85(2):177-189.
-
2PAPADOPOULOS MC,VERKMAN AS.Aquaporin 4 and neu- romyelitis optica[J].Lancet Neurol,2012,11(6):535-544.
-
3WEINSHENKER BG,WINGERCHUK DM.The two faces of neuromyelitis optica[J].Neurology,2014,82(6):466-467.
-
4JONES MV,FOX TALBOT K,LEVY M.Evidence for classic comp-lement activity in neuromyelitisoptica[J].Clin Neuropathol,2014,33(3):251-252.
-
5MARIOS C,JEFFREY L,ALAN S.Treatment of neuromyelitis optica:state-of-the-art and emerging therapies[J].Nat Rev Neurol,2014,10(9):493-506.
-
6YAGUCHI H,SAKUSHIMA K,TAKAHASHI I,et al.Efficacy of intravenous cyclophosphamide therapy for neuromyelitis optica spectrum disorder[J].Intern Med,2013,52(9):969-972.
-
7KITLEY J,ELSONE L,GEORGE J,et al.Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrumdisor- ders with aquaporin-4 antibodies[J].Neurol Neurosurg Psychi- atry,2013,84(8):918-921.
-
8MEYTS I,JANSEN K,RENARD M,et al.Neuromyelitisoptica- IgG + optic neuritis associated with celiac disease and dysgam- maglobulinemia:ahanintrole for tacrolimus[J].Eur Paediatr Neurol,2011,15(3):265-267.
-
9KIM SH,HUH SY,LEE SJ,et al.A 5-year follow-up of ritux- imab treatment in patients with neuromyelitis optica spectrum disorder[J].JAMA Neurol,2013,70(9):1110-1117.
-
10PITTOCK SJ,LENNON VA,MCKEON A,et al.Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum dis- orders:an open-label pilot study[J].Lancet Neurol,2013,12(6):554-562.
